Neural mechanisms underlying photophobia and dry eye
Neural mechanisms underlying photophobia and dry eye
批准号:
9885368
负责人:
Anat Galor
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
AcheActivities of Daily LivingAcuteAddressAffectAftercareAgeAlgorithmsAutomobile DrivingBilateralBotulinum ToxinsCell NucleusChronicComputersControl GroupsCorneaCutaneousDarknessDataDiagnosisDiseaseDistressDrynessEsthesiaEventEyeFunctional Magnetic Resonance ImagingFunctional disorderGoalsHome environmentImageIndividualInjectionsIntrinsic driveKnowledgeLightMeasuresMedialMorbidity - disease rateNerveNerve BlockNeural PathwaysNeuraxisNeuronal PlasticityNociceptionPainPain MeasurementParticipantPathologicPathway interactionsPatientsPeripheralPhotophobiaPhotosensitivityPhysical FunctionPopulationPositioning AttributePrisonerProcessPulvinar structureQuality of lifeReadingRehabilitation therapyReportingRetinal Ganglion CellsScanningSeveritiesSignal TransductionSigns and SymptomsSomatosensory CortexStimulusStructure of trigeminal ganglionSymptomsSyndromeSystemTechnologyTestingThalamic structureTherapeuticTrigeminal NucleiTrigeminal SystemVeteransVisionWorkblood oxygen level dependentbotulinumclinical paindesigneffective therapyexperienceeye drynessimprovedindividual patientinstrumentmelanopsinmental functionmultidisciplinaryneuromechanismocular painpain sensationpain symptompainful neuropathypatient subsetsprecision medicineprogramsrelating to nervous systemresponsesexsocialstatisticssunglassestargeted treatmenttooltreatment responsetreatment strategy
中文摘要
据估计,19%的美国退伍军人患有干眼症(DE),其中眼部疼痛症状是常见的
显化。这些症状可能包括干燥感、灼热感和对光的极度敏感(即,
恐光症)。这些症状干扰了日常生活活动,包括驾驶和阅读。恐光症,
尤其是最令人痛苦的症状之一,因为它的发生导致了高发病率而没有有效的
治疗。受影响最严重的个人成为自己家中的囚犯,因为即使
少量的光。即使在不太严重的情况下,大多数人也有明显的功能限制和
经常需要在室内和室外佩戴太阳镜。关于作为基础的机制存在着知识鸿沟
这些痛苦的感觉,从而限制了针对适当的治疗策略的能力。我们的总体假设
恐光是1)三叉神经通路和2)三叉神经通路相互作用的中枢病理可塑性的指标
通过黑素途径。为了验证这一假设,在目标1中,我们定义了外周和中枢神经反应
与对照组相比,慢性眼痛和畏光患者的光线。在目标2中,我们检查
通过阻断角膜传入驱动(评估三叉神经)不同通路在畏光中的作用
和固有的光敏视网膜神经节细胞(IpRGC)驱动(以评估黑素途径)。
在目的3中,我们确定了神经阻滞联合肉毒杆菌毒素注射治疗畏光的效果。这项研究是
作为该领域取得进展的一个关键障碍,迫切需要的是缺乏关于神经通路的信息
潜伏的疾病。所产生的数据可以用于改善眼痛的康复和增加
退伍军人和非退伍军人的功能和生活质量相同。
英文摘要
It is estimated that 19% of US veterans have dry eye (DE), of which painful ocular symptoms are a common
manifestation. These can include sensations of dryness, burning, and extreme sensitivity to light (i.e.,
photophobia). The symptoms interfere with activities of daily living including driving and reading. Photophobia,
in particular, is one of the most distressing symptoms as its occurrence results in high morbidity without effective
treatment. Individuals most severely affected become prisoners in their own homes due to intolerance to even
small amounts of light. Even in less severe cases, most individuals have significant functional limitations and
often require sunglasses in and outdoors. A knowledge gap exists with regards to the mechanism that underlie
these painful sensations, thus limiting the ability to target appropriate treatment strategies. Our overall hypothesis
is that photophobia is an indicator of central pathologic plasticity of 1) trigeminal pathways, and 2) their interaction
with melanopsin pathways. To test this hypothesis, in aim 1, we define peripheral and central neural responses
to light in individuals with chronic ocular pain and photophobia as compared to controls. In aim 2, we examine
the contribution of different pathways to photophobia by blocking corneal afferent drive (to assess trigeminal
pathways) and intrinsically photosensitive retinal ganglion cell (ipRGC) drive (to assess melanopsin pathways).
In Aim 3, we determine the effect of neural blockade with botulinum toxin injection on photophobia. This study is
greatly needed, as a critical barrier to progress in the field is the lack of information on neural pathways that
underlie disease. The data generated can be used to improve the rehabilitation of ocular pain and increase
function and quality of life in veterans and non-veterans alike.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining bacterial members of the ocular surface microbiome and assessing stability over time
-
批准号:10668753
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2023
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10013711
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Neural mechanisms underlying photophobia and dry eye
-
批准号:10704725
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Neural mechanisms underlying photophobia and dry eye
-
批准号:10425233
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10293544
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunction
-
批准号:10514592
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:9176495
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:9325036
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:10011823
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
Dry Eye and Microenvironment
-
批准号:9767193
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2016
-
负责人:Anat Galor
-
依托单位:
海外基金